Imarisio P, Biamino E, Bongiorno P, Caligaris F, Demicheli G, Montalcini G, Arnaud A
Servizio di Nefrologia e Dialisi, USSL n. 68, Asti.
Minerva Urol Nefrol. 1991 Jul-Sep;43(3):143-5.
The paper reports a study carried out in the Dialysis Centres of Piedmont and the Aosta Valley on the use of erythropoietin in the treatment of anemia in patients undergoing regular dialysis. The efficacy of the drug and collateral and/or undesirable effects were evaluated. It was found that the drug was efficacious in 99.2% of the 342 patients receiving treatment on 30-6-1990, whereas undesirable effects were observed in 14.6% of cases. Data from the Nephrology and Dialysis Service in Asti are also reported.
该论文报道了一项在皮埃蒙特和奥斯塔山谷的透析中心开展的关于使用促红细胞生成素治疗接受定期透析患者贫血的研究。评估了该药物的疗效以及副作用和/或不良影响。结果发现,在1990年6月30日接受治疗的342名患者中,99.2%的患者使用该药物有效,而14.6%的病例出现了不良影响。还报告了阿斯蒂肾病与透析服务中心的数据。